Leucadia National Corporation »

Perspective Therapeutics shares owned by Leucadia National Corporation

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Leucadia National Corporation from 13F filings

Historical chart of Leucadia National Corporation investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Leucadia National Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Leucadia National Corporation

Quarter filed Position value Share count Share price at filing
2026-03-31 $765k 183k 4.17

More positions owned by Leucadia National Corporation

Spdr Gold Tr Gold Shs (GLD)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr Series Trust State Street Spd (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Select Sector Spdr Tr State Street Ene (XLE)
Amazon (AMZN)
Iren Ordinary Shares (IREN)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Wal-Mart Stores (WMT)
Mastercard Incorporated Cl A (MA)
Ashland (ASH)
Broadcom (AVGO)
Meta Platforms Cl A (META)

View all positions for Leucadia National Corporation

Top funds holding Perspective Therapeutics

TCG Crossover Management
Commodore Capital
Avidity Partners Management
BlackRock
Opaleye Management
Vanguard Capital Management
Millennium Management
Citadel Advisors
Vanguard Group
Balyasny Asset Management
Morgan Stanley
Geode Capital Management
Patient Square Capital
Nicholson Wealth Management Group
Goldman Sachs Group

View all funds holding Perspective Therapeutics